FindTrial
Sign In

Comparative study of 0.5% bupivacaine(12mg) versus 0.5% bupivacaine(8mg) with fentanyl(25µg) for vasopressor requirement in caesarean section

Comparative study of intrathecal 0.5% bupivacaine(12mg) versus 0.5% bupivacaine(8mg) with fentanyl(25µg) for ephedrine requirement in caesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032460
Enrollment
110
Registered
2021-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: 0.5% heavy bupivacaine 12 mg: One of the group will receive 0.5% heavy bupivacaine 12 mg intrathecally during spinal anaesthesia in ceaserean section patients. The mean ephedrine requir

Sponsors

MS Ramaiah medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with ASA status I or II

Exclusion criteria

Exclusion criteria: 1. ASA III or IV 2. Patient refusal 3. Pregnancy related hypertension 4. Infection at the site of injection 5. Coagulopathy disorders 6. Allergy to local anesthetics 7. Musculoskeletal deformity

Design outcomes

Primary

MeasureTime frame
To assess the mean ephedrine requirementTimepoint: Heart rate , Systolic Blood Pressure , Diastolic blood pressure and saturation will be recorded at 0 , 2, 4, 6, 8, 10, 12, 14, 20 , 25, 30, 35 minutes—

Secondary

MeasureTime frame
To assess - the sensory and motor level blockade - duration of post-operative analgesia - adverse events like nausea, vomiting and sedation Timepoint: Highest sensory level of blockade Motor level of blockade according to bromage scale Duration of post oprative analgesia presence or absent of side effects like nausea , vomiting and sedation—

Countries

India

Contacts

Public ContactDr Leena H Parate

MS Ramaiah medical college

dr_leenag@yahoo.co.in9480525925

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026